Abstract:Objective:To explore the effects of resveratrol (Res) pretreatment on myocardial ischemia reperfusion injury (MIRI) in rats.Methods:Forty-two healthy adult male SD rats were divided into four groups according to random number table method: a sham operation group (Sham group, n=12), a myocardial ischemia reperfusion injury group (IR group, n=12), a resveratrol group (Res group, n=12) and a diltiazem group (positive control group, n=6). Rats in the IR group, the Res group and the positive control group were used to establish a MIRI model through ligating the left anterior descending coronary artery for 30 min followed by reperfusion for 2 h. Rats in the Sham group were threaded without ligation alone. Before establishment of the MIRI model, rats in the Res group and the positive control group were intraperitoneally injected with 20 mg/kg resveratrol and 5 mg/kg diltiazem once per day for seven consecutive days, respectively. Those in the Sham group and the IR group were intraperitoneally injected with an equal volume of dimethyl sulfoxide (DMSO) solution once per day. Abdominal aortic blood samples were collected after reperfusion for 2 h, and the levels of serum lactate dehydrogenase (LDH) and creatine kinase isoenzymes (CK-MB) were measuredby by enzyme-linked immunosorbent assay (ELISA). Myocardial tissue was collected to calculate the percentage of myocardial infarct size, iron content, malondialdehyde (MDA) content and superoxide dismutase (SOD) activity. Western blot was used to detect the levels of glutathione peroxidase 4 (GPX4), ferritin heavy chain (FTH), and fatty acid-coenzyme A ligase 4 (fatty acid-coenzyme A ligase 4, FACL4) in myocardial tissue. Results:Compared with the Sham group: the IR group, Res group and positive control group showed increases in the levels of serum CK-MB and LDH ( P<0.05); IR group and Res group showed increases in the percentage of myocardial infarct size ( P<0.05); IR group showed increases in the iron content, MDA content and FACL4 levels ( P<0.05), and decreases in SOD activity and the levels of FTH and GPX4 in myocardial tissue ( P<0.05). Compared with the IR group: the Res group and positive control group showed significant decreases in the levels of serum CK-MB and LDH ( P<0.005), and decreases in the percentage of myocardial infarct size ( P<0.05); the Res groups presented remarkable decreases in the iron content, MDA content and FACL4 levels in myocardial tissue ( P<0.05), and increases in SOD activity and the levels of FTH and GPX4 ( P<0.05). There was no significant difference in other indexes ( P>0.05). Conclusion:Resveratrol pretreatment can relieve oxidative stress in rat myocardial tissue to inhibit ferroptosis, so as to reduce MIRI.

Resveratrol efficiently improves pulmonary function via stabilizing mast cells in a rat intestinal injury model

Effects of resveratrol on lung injury induced by intestinal ischemia-reperfusion and activation of mast cells in lung tissues of rats

Resveratrol alleviates lung ischemia and reperfusion-induced pulmonary capillary injury through modulating pulmonary mitochondrial metabolism

Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation

Resveratrol pretreatment mitigates LPS-induced acute lung injury by regulating conventional dendritic cells' maturation and function

Resveratrol Pretreatment Protects Rat Hearts from Ischemia/reperfusion Injury Partly Via a NALP3 Inflammasome Pathway.

Protective effects of resveratrol on acute lung injury induced by lipopolysaccharide in mices

RESVERATROL AMELIORATES LUNG INJURY VIA INHIBITION OF APOPTOSIS IN RATS WITH SEVERE ACUTE PANCREATITIS

The Effects of Resveratrol on Inflammation and Oxidative Stress in a Rat Model of Chronic Obstructive Pulmonary Disease

3,5,4′-Tri-o-acetylresveratrol Attenuates Seawater Aspiration-Induced Lung Injury by Inhibiting Activation of Nuclear Factor-Kappa B and Hypoxia-Inducible Factor-1Α

Resveratrol Attenuates the Inflammatory Reaction Induced by Ischemia/reperfusion in the Rat Heart.

Effects of resveratrol pretreatment on myocardial ischemia reperfusion injury

Lung Endothelial Barrier Protection by Resveratrol Involves Inhibition of HMGB1 Release and HMGB1-induced Mitochondrial Oxidative Damage Via an Nrf2-dependent Mechanism.

Resveratrol attenuates non-steroidal anti-inflammatory drug-induced intestinal injury in rats in a high-altitude hypoxic environment by modulating the TLR4/NFκB/IκB pathway and gut microbiota composition

The experimental study of resveratrol in the acute pancreatitis combined with lung injury in rats

3,5,4′-Tri-o-acetylresveratrol Ameliorates Seawater Exposure-Induced Lung Injury by Upregulating Connexin 43 Expression in Lung

3,5,4'-Tri-o-acetylresveratrol Decreases Seawater Inhalation-Induced Acute Lung Injury by Interfering with the NF-κB and I-Nos Pathways.

Resveratrol suppresses neutrophil activation via inhibition of Src family kinases to attenuate lung injury

Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway.

[Resveratrol Attenuates Hypoxia-Reperfusion Injury Induced Rat Myocardium Microvascular Endothelial Cell Dysfunction Through Upregulating PI3K/Akt/SVV Pathways].

Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats